N/A N=9 Coaching for Caregivers of Children With Spinal Cord Injury
Spinal Cord Injuries
Primary: Change in Canadian Occupational Performance Measure (COPM) — 2.48; 2.80 score on a scale — p=<0.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=47 A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
Healthy
Primary: Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of Tirzepatide From Time Zero to Infinity (AUC0toinf) — 101000; 104000 Nanogram*hour per…
Phase 3 N=204 VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
SARS-CoV Infection
Primary: Efficacy of Sabizabulin in the Treatment of SARS-CoV-2 Infection by Assessing Its Effect on the Proportion of Patients Who Died on Study. — 25; 27 Participants
N/A N=149 Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)
Type 1 Diabetes Mellitus
Primary: Glycemic Control — 11.51; 11.48; 11.55; 11.14 percentage of glycosylated hemoglobin — p=<.05
N/A N=498 Leveraging Social Networks to Increase COVID-19 Testing Uptake
Covid-19 · Substance Use · Opioid Use
Primary: Participants Who Agreed to Take a COVID-19 Rapid Test of Those Enrolled — 261; 214 participants who tested — p=0.928
N/A N=52 Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
Chronic Fatigue Syndrome
Primary: Cardiopulmonary Exercise Test (CPET) - ATVO2rel — 16.0; 10.6 mL/kg/min
Phase 2 N=22 Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance
Scars
Primary: Patient and Observer Scar Assessment Scale (POSAS) - PI Assessment — 4.4; 4.5 score on a scale
N/A N=82 Accuracy of the NICCI™ Monitor in Children and Adolescents
Surgery · Anesthesia
Primary: Difference in Blood Pressure — 11; 10; 10; 9 mm Hg
N/A N=1,552 The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial
Appendicitis
Primary: Patient-reported Quality of Life as Measured by EuroQol (EQ-5D) — 0.92; 0.91 score on a scale
Phase 2 N=101 The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
COVID-19
Primary: Number of Participants With Worsening of COVID-19 Within 28 Days — 1; 1 Participants
Phase 2 N=182 Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
Post Traumatic Stress Disorder (PTSD) · Addiction · Alcohol Abuse
Primary: Change in Alcohol Use Severity — -3.406; -3.934 standard drinks per day
Phase 2 N=31 Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
HER2/Neu Positive · Recurrent Breast Carcinoma · Stage IV Breast Cancer
Primary: Number of Patients With Grade 3 or Higher Toxicity Per Study Arm. — 2; 0 Participants
N/A N=40 Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder
Binge Eating Disorder · Overweight and Obesity
Primary: Blood Oxygen Level-dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Response to Food-specific Stop-signal Task — -0.4; -0.3 percent signal change
Phase 2 N=195 A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)
Cognitive Impairment Associated With Schizophrenia
Primary: Change From Baseline in Change From Baseline in Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB)…
N/A N=162 Evaluation of Bispectral Index (BIS™) and Levels of Sedation With Common Inhalational Anesthetics in Healthy Volunteers (OLIVER)
Anesthesia
Primary: BIS 50 — 72.3; 74.2; 76.2; 67.5 units on a scale 0-100